NKL

NK cell line, established from patient with CD3-, CD16+,CD56+, large granulocyte leukemia

Cell Type:
Natural Killer (NK)
Tissue Origin:
blood
Species:
human
Research Area:
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V O-017 2e6 40-70% 90% Plasmid (general) 2 µg 100 µl I/II/2b

Citations (7)

Categories:
Transfection 
Authors:
Li C, Ge B, Nicotra M, Stern JN, Kopcow HD, Chen X, Strominger JL 
In:
Proc Natl Acad Sci USA (2008) 105(8): 3017-22 
Categories:
Transfection 
Authors:
Marusina AI, Burgess SJ, Pathmanathan I, Borrego F, Coligan JE 
In:
J Immunol (2008) 180(1): 409-17 
Categories:
Transfection 
Authors:
Walzer T, Blery M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, Andre P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagne F, Vivier E 
In:
Proc Natl Acad Sci USA (2007) 104(9): 3384-9 
Categories:
Transfection 
Authors:
Burgess SJ, Marusina AI, Pathmanathan I, Borrego F and Coligan JE 
In:
J Immunol (2006) 176(3): 1490-1497 
Categories:
Transfection 
Authors:
Marusina AI, Kim DK, Lieto LD, Borrego F and Coligan JE 
In:
J Immunol (2005) 174(4): 2152-2159 
Categories:
Transfection 
Authors:
Maasho K, Marusina A, Reynolds NM, Coligan JE and Borrego F 
In:
J Immunol Methods (2004) 284: 133-140 
Categories:
Transfection 
Authors:
Trompeter HI, Weinhold S, Thiel C, Wernet P and Uhrberg M 
In:
J Immunol Methods (2003) 274: 245-256 
+ Show All